Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate modelCentral MessagePerspective

Objectives: Palliative treatment of cyanotic congenital heart disease (CCHD) uses systemic-to-pulmonary conduits, often a modified Blalock–Taussig–Thomas shunt (mBTTs). Expanded polytetrafluoroethylene (ePTFE) mBTTs have associated risks for thrombosis and infection. The Human Acellular Vessel (HAV)...

全面介紹

書目詳細資料

Principais autores:	Kevin M. Nash, PhD, Brian A. Boe, MD, Sergio A. Carrillo, MD, Andrew Harrison, AS, ARRT, Ryuma Iwaki, MD, John Kelly, MD, Robert D. Kirkton, PhD, Ramkumar Krishnamurthy, PhD, Jeffrey H. Lawson, MD, PhD, Yuichi Matsuzaki, MD, PhD, Heather L. Prichard, PhD, Kejal Shah, MD, Toshiharu Shinoka, MD, PhD, Christopher K. Breuer, MD
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2023-09-01
叢編:	JTCVS Open
主題:	congenital heart disease tissue-engineered vascular grafts Blalock–Taussig-Thomas shunt
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2666273623002085
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!